Records containing: Hodgkin Lymphoma, Adult
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
-
CLINICAL_TRIALS study record update · 2026-03-17Pembrolizumab and GVD With ctDNA-guided Consolidation in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma: A Multicenter Phase 2 Study of the University of California Hematologic Malignancies Consortium
-
CLINICAL_TRIALS study record update · 2025-11-26Flat-dose Nivolumab (40 mg) in Combination With Doxorubicin, Vinblastine, and Dacarbazine (AVD) for Newly Diagnosed Advanced Classic Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2025-08-20A Phase 1 Study of Patient-Derived Multi-Tumor-Associated Antigen-Specific T Cells (MT-601) Administered to Patients With Relapsed or Refractory Non-Hodgkin and Hodgkin Lymphoma (APOLLO)
-
CLINICAL_TRIALS study record update · 2024-09-27First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-02-26A Randomized Phase IIb Study, Evaluating Efficacy of Salvage Therapy With Brentuximab Vedotin-ESHAP vs ESHAP in Patients With Relapsed / Refractory Classical Hodgkin's Lymphoma, Followed by Brentuximab Vedotin Consolidation (Instead of Autologous Hematopoietic Stem Cell Transplantation) in Those Who Attained a Metabolic Complete Remission After Salvage Therapy
-
CLINICAL_TRIALS study record update · 2024-02-01An Open-Label, Single Arm, Multi-Center, Phase 2 Study of PD-1 Antibody SHR-1210 in Subjects With Relapsed or Refractory Classic Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2024-01-09Real World Evidence of Brentuximab Vedotin Consolidation in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma Who Receive Salvage Chemotherapy and Autologous Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2023-11-18Phase II Study to Evaluate the Clinical Potential of 68GaNOTA-Anti-MMR-VHH2 for in Vivo Imaging of MMR-expressing Macrophages by Means of Positron Emission Tomography (PET) in Oncological Lesions,Cardiovascular Atherosclerosis,Syndrome With Abnormal Immune Activation and sarcoïdosis
-
CLINICAL_TRIALS study record update · 2023-05-10Physical Capacity Evaluation and Effects of ExerciseTraining on Hodgkin Lymphoma Survivors
-
CLINICAL_TRIALS study record update · 2023-04-05A Phase 2 Multi-Center Study Evaluating the Safety and Efficacy of CD30-Directed Genetically Modified Autologous T Cells (CD30.CAR-T) in Adult and Pediatric Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2021-12-17PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2021-12-03Compassionate Use Re-Infusion of ATLCAR.CD30
-
CLINICAL_TRIALS study record update · 2021-04-01SPECT Imaging of Lymphoma Using Technetium-99m Labeled 1-Thio-D-Glucose (99mTc-1-thio-D-glucose)
-
CLINICAL_TRIALS study record update · 2020-12-04Immunotherapy With Autologous CAR30 T Cells for Patients With Classic Hodgkin Lymphoma and Non-Hodgkin T-cell Lymphoma With CD30 Expression.
-
CLINICAL_TRIALS study record update · 2019-11-26A Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study
-
CLINICAL_TRIALS study record update · 2019-06-17Outcome of Hodgkin Lymphoma Patients Over Than 60 Years Treated by Chemotherapy and/or Radiotherapy: a Retrospective Study
-
CLINICAL_TRIALS study record update · 2017-10-12LCCC 1115: A Pilot Feasibility Trial of Induction Chemotherapy With ABVD Followed by Brentuximab Vedotin (SGN-35) Consolidation in Patients With Previously Untreated Non-Bulky Stage I or II Hodgkin Lymphoma (HL)